CONTACT US LOCATIONS HOME ABOUT VALEANT OPERATIONAL EXPERTISE INVESTOR RELATIONS CAREER OPPORTUNITIES Patients Trusted expertise in: Prescription Brands Consumer Brands Branded Generics Special Programs: Patient Assistance Program Unrestricted Educational Grants READ MORE What We Do Download Resources Product Information Regional Information Asia Pacific and Africa | Canada | Europe and Middle East | Latin America | United States Research & Development Dermatology & Neurology Pipeline READ MORE News & Stock &amp;amp;amp;amp;ampamp;lt;p&amp;amp;amp;amp;ampamp;gt;Your browser does not support iframes.&amp;amp;amp;amp;ampamp;lt;/p&amp;amp;amp;amp;ampamp;gt; Details on Valeant's proposal to combine with Allergan can be found here. A letter to healthcare professionals from J. Michael Pearson can be found here. About Valeant Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops and markets prescription and non-prescription pharmaceutical products that make a meaningful difference in patients' lives. The company’s growth strategy is to acquire, develop and commercialize new products through strategic partnerships, and strategically expand its pipeline by adding new compounds or products through product or company acquisitions. Headquartered in Laval, Quebec, Valeant has approximately 17,000 employees worldwide and is listed on both the New York Stock and Toronto Stock Exchanges under the symbol VRX. Copyright © 2014 Valeant. All rights reserved. PRIVACY POLICY TERMS & CONDITIONS SITEMAP